| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8815523 | Journal of Affective Disorders | 2018 | 7 Pages |
Abstract
miRNA findings in BD significantly vary between studies, but are consistent to suggest a key role for these molecules in BD's pathophysiology and treatment, particularly miR-34a and miR-137. Accordingly, miRNA might represent important biomarkers of illness to be used in the clinical settings, and potentially also for the development of novel therapeutics for BD in the near future.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Gabriel R. Fries, Andre F. Carvalho, Joao Quevedo,